What is it about?
This editorial discussed a recent study published in Diabetes, which identified the stress response protein Regulated in Development and DNA Damage 1 (REDD1) as a potential therapeutic target for diabetic nephropathy.
Featured Image
Read the Original
This page is a summary of: Targeting REDD1 in Podocytes: A Promising Strategy for Mitigating Diabetic Kidney Injury, Diabetes, February 2025, American Diabetes Association,
DOI: 10.2337/dbi24-0042.
You can read the full text:
Contributors
The following have contributed to this page
